Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$22.72 - $29.68 $12.8 Million - $16.8 Million
-565,500 Reduced 97.4%
15,100 $436,000
Q3 2023

Nov 14, 2023

SELL
$27.57 - $32.91 $1.92 Million - $2.29 Million
-69,656 Reduced 10.71%
580,600 $16 Million
Q2 2023

Aug 14, 2023

BUY
$29.91 - $38.73 $15.8 Million - $20.4 Million
527,375 Added 429.18%
650,256 $19.5 Million
Q1 2023

May 15, 2023

BUY
$34.93 - $42.03 $413,396 - $497,425
11,835 Added 10.66%
122,881 $4.45 Million
Q4 2022

Feb 14, 2023

SELL
$31.09 - $37.88 $255,932 - $311,828
-8,232 Reduced 6.9%
111,046 $3.96 Million
Q3 2022

Nov 14, 2022

BUY
$28.79 - $35.41 $1.06 Million - $1.31 Million
36,878 Added 44.75%
119,278 $4.04 Million
Q2 2022

Aug 11, 2022

BUY
$25.33 - $34.25 $592,722 - $801,450
23,400 Added 39.66%
82,400 $2.38 Million
Q1 2022

May 13, 2022

BUY
$28.51 - $32.9 $1.68 Million - $1.94 Million
59,000 New
59,000 $1.91 Million
Q2 2020

Aug 13, 2020

SELL
$17.09 - $24.89 $9.45 Million - $13.8 Million
-552,800 Closed
0 $0
Q1 2020

May 14, 2020

SELL
$14.45 - $24.69 $329,460 - $562,932
-22,800 Reduced 3.96%
552,800 $9.95 Million
Q4 2019

Feb 14, 2020

BUY
$19.93 - $29.13 $3.17 Million - $4.63 Million
159,000 Added 38.17%
575,600 $13.7 Million
Q3 2019

Nov 14, 2019

SELL
$25.47 - $33.37 $1.28 Million - $1.68 Million
-50,400 Reduced 10.79%
416,600 $11.4 Million
Q2 2019

Aug 14, 2019

BUY
$29.96 - $38.87 $5.27 Million - $6.84 Million
176,000 Added 60.48%
467,000 $15.5 Million
Q1 2019

May 15, 2019

SELL
$32.77 - $41.99 $1.77 Million - $2.27 Million
-54,100 Reduced 15.68%
291,000 $10.2 Million
Q4 2018

Feb 12, 2019

SELL
$30.84 - $49.51 $1.28 Million - $2.05 Million
-41,400 Reduced 10.71%
345,100 $11.5 Million
Q3 2018

Nov 13, 2018

BUY
$42.7 - $56.55 $2.56 Million - $3.39 Million
59,900 Added 18.34%
386,500 $19.5 Million
Q2 2018

Aug 07, 2018

BUY
$44.1 - $59.85 $1.67 Million - $2.26 Million
37,800 Added 13.09%
326,600 $19.5 Million
Q1 2018

May 09, 2018

BUY
$37.15 - $46.9 $1.8 Million - $2.27 Million
48,400 Added 20.13%
288,800 $13.2 Million
Q4 2017

Feb 14, 2018

BUY
$36.4 - $42.6 $8.75 Million - $10.2 Million
240,400
240,400 $9.58 Million

Others Institutions Holding SUPN

About SUPERNUS PHARMACEUTICALS, INC.


  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $1.94B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Bellevue Group Ag Portfolio

Follow Bellevue Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.